Elixinol Wellness Ltd (AU:EXL) has released an update.
Elixinol Wellness Ltd has successfully completed the sale of its minority stake in Altmed Pets LLC, receiving approximately $2.3 million, marking significant progress towards financial break-even. The company highlighted its strategic focus on expanding its brand portfolio in Australia, which has seen record revenues in the first quarter, as well as a positive contribution to EBITDA from its lean e-commerce business in America.
For further insights into AU:EXL stock, check out TipRanks’ Stock Analysis page.
